Citigroup Inc Eton Pharmaceuticals, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Citigroup Inc holds 26,495 shares of ETON stock, worth $330,127. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,495

Holding current value

$330,127

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Nov 12, 2024	BUY	$3.28 - $6.0 $86,903 - $158,970	26,495 New	26,495 $158,000
Q4 2023 Feb 09, 2024	BUY	$3.45 - $4.66 $7,693 - $10,391	2,230 New	2,230 $9,000

Others Institutions Holding ETON

# of Institutions

Shares Held

9.44M

Call Options Held

261K

Put Options Held

500

Opaleye Management Inc. Boston, MA

2.78M
Shares

$34.6 Million
3.05% of portfolio
Vanguard Group Inc Valley Forge, PA

1.03M
Shares

$12.8 Million
0.0% of portfolio
Nantahala Capital Management, LLC New Canaan, CT

999K
Shares

$12.4 Million
0.36% of portfolio
Westside Investment Management, Inc.

619K
Shares

$7.71 Million
0.79% of portfolio
Acuitas Investments, LLC

580K
Shares

$7.23 Million
1.66% of portfolio

View Full List

About Eton Pharmaceuticals, Inc.

Ticker ETON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,297,000
Market Cap $315M
Description
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...

More about ETON

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account